Search results for "Imipenem"

showing 10 items of 20 documents

Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of…

2021

Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

0301 basic medicineImipenemKlebsiella pneumoniaemedicine.drug_classMitomycin030106 microbiologyAntibioticsResistanceDrug repurposingMicrobial Sensitivity TestsBacteriophage therapybeta-LactamasesMicrobiologyPersistence03 medical and health sciencesMechanisms of Resistancemedicinepolycyclic compoundsHumansPharmacology (medical)BacteriophagesPathogenhealth care economics and organizationsPharmacologybiologyMitomycin CBroth microdilutionbiochemical phenomena metabolism and nutritionbiology.organism_classificationAntimicrobialhumanitiesAnti-Bacterial AgentsKlebsiella InfectionsSynergyImipenemKlebsiella pneumoniae030104 developmental biologyInfectious DiseasesLytic cyclemedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms

2017

There is urgent need for new therapeutic strategies to fight the global threat of antibiotic resistance. The focus of this Perspective is on chemical agents that target the most common mechanisms of antibiotic resistance such as enzymatic inactivation of antibiotics, changes in cell permeability, and induction/activation of efflux pumps. Here we assess the current landscape and challenges in the treatment of antibiotic resistance mechanisms at both bacterial cell and community levels. We also discuss the potential clinical application of chemical inhibitors of antibiotic resistance mechanisms as add-on treatments for serious drug-resistant infections. Enzymatic inhibitors, such as the deriv…

0301 basic medicineImipenemmedicine.drug_classAvibactam030106 microbiologyAntibioticsDrug resistancePharmacologyBiologySettore BIO/19 - Microbiologia Generalemedicine.disease_causeMicrobiology03 medical and health scienceschemistry.chemical_compoundAntibiotic resistanceDrug DiscoverymedicineHumansPseudomonas InfectionsBeta-Lactamase InhibitorsPseudomonas aeruginosaDrug Discovery3003 Pharmaceutical ScienceEnterobacteriaceae InfectionsDrug Resistance MicrobialSettore CHIM/08 - Chimica FarmaceuticaImipenemchemistryMolecular Medicine; Drug Discovery3003 Pharmaceutical ScienceMolecular MedicineEffluxbeta-Lactamase InhibitorsAzabicyclo Compoundsmedicine.drugJournal of Medicinal Chemistry
researchProduct

Re: Antimicrobial Resistance in More Than 100,000 Escherichia coli Isolates According to Culture Site and Patient Age, Gender, and Location

2011

ABSTRACT Escherichia coli and the antimicrobial pressure exerted on this microorganism can be modulated by factors dependent on the host. In this paper, we describe the distribution of antimicrobial resistance to amikacin, tobramycin, ampicillin, amoxicillin clavulanate, cefuroxime, cefoxitin, cefotaxime, imipenem, ciprofloxacin, fosfomycin, nitrofurantoin, and trimetoprim-sulfametoxazole in more than 100,000 E. coli isolates according to culture site and patient age, gender, and location. Bayesian inference was planned in all statistical analysis, and Markov chain Monte Carlo simulation was employed to estimate the model parameters. Our findings show the existence of a marked difference in…

AdultMaleCefotaximeAdolescentmedicine.drug_classUrologyAntibioticsCefotaximeDrug resistanceFosfomycinBiologymedicine.disease_causeEpidemiology and SurveillanceMicrobiologyYoung AdultAntibiotic resistanceFosfomycinCiprofloxacinPatient ageDrug Resistance Multiple BacterialEscherichia coliHumansMedicinePharmacology (medical)ChildAmikacinEscherichia coliEscherichia coli InfectionsAgedRetrospective StudiesAntibacterial agentAged 80 and overPharmacologybusiness.industryInfantMiddle AgedAntimicrobialAnti-Bacterial AgentsImipenemInfectious DiseasesNitrofurantoinAmikacinChild PreschoolTobramycinAmpicillinFemalebusinessmedicine.drugJournal of Urology
researchProduct

Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.

1997

Previously, it has been postulated that the porin OprC facilitates the diffusion of ceftazidime through the outer membrane of Pseudomonas aeruginosa. To further investigate this claim, the outer membrane protein (OMP) profiles of 22 ceftazidime-susceptible clinical isolates were analyzed. No correlation was found between MIC values and the level of expression of OprC. Further, OprC was either undetectable or expressed in reduced amounts in 12 isolates. In contrast, OprF and OprE were present in all isolates studied. This study suggests that OprC is dispensable for the permeation of ceftazidime through the outer membrane of P. aeruginosa.

CeftazidimePorinsmedicine.disease_causePorinaCeftazidimeMicrobiologyBacterial ProteinsDrug DiscoverymedicineHumansPharmacology (medical)Antibacterial agentPharmacologybiologyPseudomonas aeruginosaGeneral Medicinebiology.organism_classificationCephalosporinsImipenemInfectious DiseasesOncologyMembrane proteinSpainPorinPseudomonas aeruginosaThienamycinsBacterial outer membranePseudomonadaceaemedicine.drugBacterial Outer Membrane ProteinsChemotherapy
researchProduct

Aeromonas hydrophila subsp. dhakensis isolated from feces, water and fish in Mediterranean Spain.

2012

Eight Aeromonas hydrophila-like arabinose-negative isolates from diverse sources (i.e., river freshwater, cooling-system water pond, diseased wild European eels, and human stools) sampled in Valencia (Spain) during 2004-2005, were characterized by 16S rRNA gene sequencing and extensive biochemical testing along with reference strains of most Aeromonas species. These isolates and all reference strains of A. hydrophila subsp. dhakensis and A. aquariorum showed a 16S rRNA sequence similarity of 99.8-100%, and they all shared an identical phenotype. This matched exactly with that of A. hydrophila subsp. dhakensis since all strains displayed positive responses to the Voges-Prokauer test and to t…

DNA BacterialFresh WaterMicrobial Sensitivity TestsAmoxicillin-Potassium Clavulanate CombinationCefoxitinFecesDrug Resistance Multiple BacterialRNA Ribosomal 16SAnimalsHumansTicarcillinemerging pathogen16S rRNA gene sequencingBase SequenceSequence Analysis RNAA. hydrophila subsp. dhakensisFishesArticlesbiochemical phenomena metabolism and nutritionbacterial infections and mycosesAeromonas hydrophilaImipenemPhenotypeSpainphenotypic profilebacteriaMicrobes and environments
researchProduct

Characterization of the Carbapenem-Hydrolyzing Oxacillinase Oxa-58 in an Acinetobacter Genospecies 3 Clinical Isolate

2008

ABSTRACT Based on imipenem resistance in an Acinetobacter genospecies 3 clinical isolate, we were able to identify, for the first time in this genomic species, a plasmid-encoded bla OXA-58 gene that was 100% homologous to the same gene in Acinetobacter baumannii .

ImipenemCarbapenemMolecular Sequence DataMicrobial Sensitivity TestsBiologybeta-LactamasesMicrobiologyPlasmidBacterial ProteinsMechanisms of Resistancepolycyclic compoundsmedicineHumansPharmacology (medical)Antibacterial agentPharmacologyAcinetobacterBase SequenceSequence Analysis DNAbiochemical phenomena metabolism and nutritionAcinetobacterbacterial infections and mycosesbiology.organism_classificationAnti-Bacterial AgentsAcinetobacter baumanniiImipenemInfectious DiseasesCarbapenemsNeisseriaceaeBacteriaAcinetobacter InfectionsPlasmidsmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

ESBL-producing Klebsiella pneumoniae in a University hospital: Molecular features, diffusion of epidemic clones and evaluation of cross-transmission.

2021

The worldwide spread of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL-Kp) is a significant threat. Specifically, various pandemic clones of ESBL-Kp are involved in hospital outbreaks and caused serious infections. In that context, we assessed the phenotypic and molecular features of a collection of ESBL-Kp isolates in a French university hospital and evaluated the occurrence of potential cross-transmissions. Over a 2-year period (2017–2018), 204 non-duplicate isolates of ESBL-Kp were isolated from clinical (n = 118, 57.8%) or screening (n = 86, 42.2%) sample cultures. These isolates were predominantly resistant to cotrimoxazole (88.8%) and ofloxacin (82.8%) but remaine…

ImipenemNosocomial InfectionsEpidemiologyKlebsiella pneumoniaePathology and Laboratory MedicineKlebsiella PneumoniaeHospitals UniversityMedical ConditionsKlebsiellaDrug Resistance Multiple BacterialPandemicMedicine and Health Sciences0303 health sciencesMultidisciplinarybiologyQRHospitalsBacterial PathogensAnti-Bacterial AgentsBacterial Typing Techniques3. Good healthIntensive Care UnitsInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMedical MicrobiologyAmikacinGenetic EpidemiologyMedicinePathogensResearch Articlemedicine.drugScienceContext (language use)Research and Analysis MethodsMicrobiologybeta-LactamasesMicrobiology03 medical and health sciencesmedicineHumansGenetic variabilityMolecular Biology TechniquesMolecular BiologyMicrobial PathogensRetrospective Studies030304 developmental biologyBacteria030306 microbiologyOrganismsBiology and Life SciencesOutbreakbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesKlebsiella InfectionsHealth CareHealth Care FacilitiesMultilocus sequence typing[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCloningPLoS ONE
researchProduct

Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report.

2012

Abstract Introduction Rapidly growing mycobacteria are opportunistic pathogens in patients with underlying risk factors. Mycobacterium abscessus subsp. bolletii is a newly recognized member of rapidly growing mycobacteria, isolated from respiratory tract and cutaneous infections. Case presentation We describe a case of chronic disseminated infection caused by M. abscessus subsp. bolletii in a 38-year-old Sri Lankan man with idiopathic CD4+ T lymphocytopenia. Idiopathic CD4+ T lymphocytopenia is a rare cause of immunodysfunction that, similar to human immunodeficiency virus infection, causes a depletion of CD4+ T lymphocytes. M. abscessus subsp. bolletii infection was diagnosed by culture is…

ImipenemSettore MED/07 - Microbiologia E Microbiologia ClinicaDisseminated infectionlcsh:MedicineCase ReportMycobacterium abscessusMicrobiologyMycobacterium abscessus subsp. bolletii rapidly growing mycobacteriaClarithromycinMycobacterium bolletiiClarithromycinmedicineCefoxitinMedicine(all)biologybusiness.industryPatient affectedlcsh:RMycobacterium bolletiiGeneral MedicineMycobacterium bolletii; idiopathic CD4+ T lymphocytopeniabiology.organism_classificationbacterial infections and mycosesCD4+ T lymphocytopeniaImmunologyidiopathic CD4+ T lymphocytopeniaSputumbacteriaCD4+ T-Lymphocytopeniamedicine.symptom<it>Mycobacterium abscessus</it> subsp. <it>bolletii</it> rapidly growing mycobacteriabusinessmedicine.drug
researchProduct

&lt;i&gt;Aeromonas hydrophila&lt;/i&gt; subsp. &lt;i&gt;dhakensis&lt;/i&gt; Isolated from Feces, Water and Fish in Mediterranean Spain

2012

Eight Aeromonas hydrophila-like arabinose-negative isolates from diverse sources (i.e., river freshwater, cooling-system water pond, diseased wild European eels, and human stools) sampled in Valencia (Spain) during 2004–2005, were characterized by 16S rRNA gene sequencing and extensive biochemical testing along with reference strains of most Aeromonas species. These isolates and all reference strains of A. hydrophila subsp. dhakensis and A. aquariorum showed a 16S rRNA sequence similarity of 99.8–100%, and they all shared an identical phenotype. This matched exactly with that of A. hydrophila subsp. dhakensis since all strains displayed positive responses to the Voges-Prokauer test and to t…

ImipenembiologySoil ScienceVirulencePlant ScienceGeneral Medicinebiochemical phenomena metabolism and nutritionRibosomal RNAbacterial infections and mycoses16S ribosomal RNAbiology.organism_classificationMicrobiologyAeromonasTicarcillinmedicinebacteriaCefoxitinEcology Evolution Behavior and SystematicsFecesmedicine.drugMicrobes and Environments
researchProduct

Outbreak of IMI-1 Carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean)

2018

International audience; The spread of carbapenemase-producing Enterobacteriaceae in the Southwest Indian Ocean islands is poorly known. Here we describe an outbreak of colistin-resistant Enterobacter cloacae harbouring blaIMI-1 in the French overseas department of Mayotte. Between October 2015 and January 2017, all isolates of imipenem-non-susceptible E. cloacae at Mayotte Medical Center and University Hospital of Reunion Island were screened for carbapenemase production. Positive isolates were typed by pulsed-field gel electrophoresis and whole-genome sequencing (WGS)-based multilocus sequence typing (MLST), and all β-lactamase genes were identified by PCR and sequencing. Resistance profil…

Male0301 basic medicineImipenembla(IMI-1)Carbapenem-resistant enterobacteriaceaeComorosDisease Outbreaks[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyPharmacology (medical)Enterobacteriaceae InfectionsGeneral MedicineMiddle AgedFrench overseas islandAnti-Bacterial AgentsElectrophoresis Gel Pulsed-Field3. Good healthInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyFemalemedicine.drugAdultErtapenemMicrobiology (medical)Adolescent030106 microbiologyMayotteMicrobial Sensitivity TestsBiologybeta-LactamasesMicrobiologyCarbapenemaseYoung Adult03 medical and health sciencesBacterial Proteins[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyEnterobacter cloacaePulsed-field gel electrophoresismedicineHumansEtestColistinOutbreakOutbreakbiology.organism_classificationCephalosporinsImipenemCarbapenem-Resistant EnterobacteriaceaeCarbapenemsColistinMultilocus sequence typingEnterobacter cloacaeGenome BacterialMultilocus Sequence Typing
researchProduct